Home / Market Reports / Pharma & Healthcare
/ Global Pharma-Grade Hyaluronic Acid Market Growth 2024-2030
Global Pharma-Grade Hyaluronic Acid Market Growth 2024-2030
Product Code:867491
Published Date: Sep 19,2024
Pages: 105
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint.
Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large: human synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3–4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors. In this report, we only study the Pharma-Grade Hyaluronic Acid.
The global Pharma-Grade Hyaluronic Acid market size is projected to grow from US$ 198 million in 2024 to US$ 364 million in 2030; it is expected to grow at a CAGR of 10.7% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pharma-Grade Hyaluronic Acid Industry Forecast” looks at past sales and reviews total world Pharma-Grade Hyaluronic Acid sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharma-Grade Hyaluronic Acid sales for 2024 through 2030. With Pharma-Grade Hyaluronic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma-Grade Hyaluronic Acid industry.
This Insight Report provides a comprehensive analysis of the global Pharma-Grade Hyaluronic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma-Grade Hyaluronic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharma-Grade Hyaluronic Acid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma-Grade Hyaluronic Acid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma-Grade Hyaluronic Acid.
The rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. the growing prevalence of osteoarthritis has fueled demand for hyaluronic acid-based treatments, as it is used in viscosupplementation injections to relieve joint pain. Rising consumer awareness of health, along with advancements in biotechnology, has further expanded the market's growth.
However, adverse effects associated with treatment or therapy such as redness and itching, as well as high production costs and regulatory hurdles. The process of extracting and purifying hyaluronic acid, particularly from natural sources, can be expensive, leading to higher product prices. Additionally, the stringent regulatory requirements for pharmaceutical-grade products create barriers for manufacturers, as they must meet rigorous standards for safety and efficacy. These factors can limit the entry of new players into the market and slow down overall growth.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharma-Grade Hyaluronic Acid market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Microbial Fermentation
Animal Tissue
Segmentation by Application:
Injection Product
Eye Drops
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharma-Grade Hyaluronic Acid market?
What factors are driving Pharma-Grade Hyaluronic Acid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharma-Grade Hyaluronic Acid market opportunities vary by end market size?
How does Pharma-Grade Hyaluronic Acid break out by Type, by Application?